×

Register now for full access to all the content

First Name
Last Name
Company Name
Title
Country
Thank you for registering!
Error - something went wrong!
   

Compound Interest: Evidence-Based Prioritization

August 22, 2017

Before a trial has gone too far and too much money has already been spent, evidence-based prioritization helps to identify the right product for the right indication. This minimizes investment risks and avoids unnecessary competition.

Predicting the success of the entire drug discovery process using an evidence-based approach at the start of development can inform trial design, feasibility and commercial strategy. 

This exercise prevents:
• Competition at the reimbursement stage 
• Missed collaboration opportunities
• Investment risk 

This exercise identifies: 
• Potential market size 
• Likely competitor developments 
• Information already known about a particular compound’s safety

Previous Flipbook
Price Optimization: A Global Strategy for Local Markets
Price Optimization: A Global Strategy for Local Markets

Learn more about price optimization here!

Next Flipbook
Comparative Effectiveness Research: Are we there yet?
Comparative Effectiveness Research: Are we there yet?

Learn more about Comparative Effectiveness Research here!